Clinical Trial Update: Pentoxifylline Add-on Therapy for Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describes pentoxifylline as add-on therapy for schizophrenia in Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Mazra Mental Health Center | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: UNKNOWN